Whilst previous studies have examined the association between circulating pro-inflammatory cytokines and cognitive dysfunction in older adults with T2DM (26–28), no study has examined the relationship between NLRP3 responsiveness and cognitive function in T2DM, which may represent an important common pathway mediating AD risk in midlife T2DM. The gene discussed is NLRP3; the disease is Alzheimer disease.